India's Shilpa Medicare up after unit gets suitability certificate for API
04/10/2024 05:09
** Shares of Shilpa Medicare SHME.NS rise 2% to 820 rupees
** Pharma co's unit received certificate of suitability from
European Directorate for Quality of Medicines and Healthcare
(EDQM) for Desmopressin, an active pharma ingredient (API)
** Desmopressin is used to treat central diabetes insipidus
and bedwetting
** Stock has surged over two-fold so far this year vs a 37%
rise in Nifty pharma index .NIPHARM
(Reporting by Ashna Teresa Britto in Bengaluru)
((AshnaTeresa.Britto@thomsonreuters.com))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026